Table 1. Patient characteristics .... | American Society of Hematology

Table 1.

Patient characteristics

	Prophylactic granulocyte transfusions: cohort A; n = 83	No prophylactic granulocyte transfusions: cohort B; n = 142	P
Median age, y (range)	44 (13-68)	46 (17-70)	.85^*
Diagnosis			.052^†
Acute leukemia	36 (43.4%)	61 (43.0%)
Non-Hodgkin lymphoma	17 (20.5%)	37 (26.0%)
Chronic myelogeneous leukemia	17 (20.5%)	18 (12.7%)
Other	13 (14.6%)	26 (18.3%)
GVHD
Grades I-IV	59 (71.0%)	94 (66.2%)	.64^†
Grades III-IV	10 (12.0%)	14 (9.8%)	.68^†

	Prophylactic granulocyte transfusions: cohort A; n = 83	No prophylactic granulocyte transfusions: cohort B; n = 142	P
Median age, y (range)	44 (13-68)	46 (17-70)	.85^*
Diagnosis			.052^†
Acute leukemia	36 (43.4%)	61 (43.0%)
Non-Hodgkin lymphoma	17 (20.5%)	37 (26.0%)
Chronic myelogeneous leukemia	17 (20.5%)	18 (12.7%)
Other	13 (14.6%)	26 (18.3%)
GVHD
Grades I-IV	59 (71.0%)	94 (66.2%)	.64^†
Grades III-IV	10 (12.0%)	14 (9.8%)	.68^†

Wilcoxon Mann-Whitney test.

Fisher exact test.